Search
for
Sort by
Research 91–120 of 1000+
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Psoriasis and psoriatic arthritis patient productivity burden in the United States
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- New treatments for rheumatoid arthritis
- A Brief Review on Acne Vulgaris: Chronic Inflammatory Disease
- Anti-inflammatory, cyclooxygenase inhibitory and antioxidant activities of standardized extracts of Tridax procumbens L.
- Symptom management in inflammatory bowel disease
- Regulatory T cells in inflammatory skin disease: from mice to humans
- Latest Advances in Inflammatory Skin Disease
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Serum level of calprotectin as a new inflammatory marker in patients with alopacia areata
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Serum sickness–like reaction in children: A retrospective review
- 0413 IL-17 Inhibitors vs. methotrexate in preventing new-onset psoriatic arthritis in psoriasis patients: a retrospective population-level analysis
- Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising
- Clinical Significance of Dense Fine Speckled Pattern in Anti-nuclear Antibody Test using Indirect Immunofluorescence Method
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- SP0227 Case 1 Presentation: Arthritis, Lupus and More. Rhupus or Polyautoimmunity?
- Trends in the presence or absence of transaminitis and/or leukopenia in pediatric patients treated with methotrexate for inflammatory skin disease
- Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
- Secondary cicatricial and other permanent alopecias
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- The Role of Janus Kinase Inhibitors in Dermatology